TP53INP1, IGF1 and ZMAT3 were differentially expressed in clinical samples of lung adenocarcinoma with BM, while miR-106a and TP53INP1 showed a significant negative correlation. This evidence concerns the gene ZMAT3 and lung adenocarcinoma.